Diverse tumorigenic pathways in ovarian serous carcinoma.
about
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesisEndometriosis and ovarian cancer: links, risks, and challenges facedRAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancerProteomics of ovarian cancer: functional insights and clinical applicationsDistinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.Ovarian cancer: pathology, biology, and disease modelsNew developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapyBRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.Differential analysis of ovarian and endometrial cancers identifies a methylator phenotypeExpression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.SNP 1772 C > T of HIF-1α gene associates with breast cancer risk in a Taiwanese population.Molecular genetic analysis of ovarian serous cystadenomas.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Estrogen biosynthesis and action in ovarian cancer.Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinomaFallopian tube origin of supposed ovarian high-grade serous carcinomas.Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problemsIntratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasPrognostic relevance of acquired uniparental disomy in serous ovarian cancer.Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinasesOvarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.Origins and molecular pathology of ovarian cancer.MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.The insulin and igf-I pathway in endocrine glands carcinogenesisIdentification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.Serous and mucinous borderline (low malignant potential) tumors of the ovary.Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?Overexpression of S100A14 in human serous ovarian carcinomaQuaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens
P2860
Q26822545-23D1247A-51B9-43D5-9C5C-A8E253E484A6Q27003273-0593B7F3-A242-43A0-A714-D3C9A919B37CQ27316858-CBECA767-0C5E-4678-9A11-B7A86846150DQ28082632-7E6BD50E-69CA-4FFD-81F3-78E5CAEF860AQ31141440-89797850-CF53-4F31-BADF-9E1B7F89632CQ33387074-3F27C44D-A2EA-446B-AF14-4B1C31AB4BE4Q33511864-C96391E8-13B5-4289-AF67-744F1BAA4729Q33580777-2EFBDFCA-B361-4582-BDC2-3A3EACDE6BB8Q33807748-013E6DE4-8527-4228-BA44-4BC07B227380Q33824552-D18C6A46-A78C-40FD-B53E-FD99A3C370A8Q34162272-C02A77C9-DDA8-4A00-8E8E-5D1B2899A0C3Q34189765-00AC5E24-B82C-4756-8ED6-B0606D28B0EDQ34216967-44C2AA8D-A9B1-42CF-A133-BAED78E72CC5Q34247030-C2C0B01B-17B6-4FC6-A8B2-D047B7BB5E4EQ34308729-41F75238-B967-443A-9AC2-FAE6BA15E20FQ34312494-6662F54C-FAC8-46FC-B31A-87A51F47412FQ34361640-A617A565-F8EB-4A71-90FC-7E14A943738EQ34496401-7ACF9D2B-1A43-4292-8B1E-970169F5DACCQ34595670-43C753FE-1D10-47F9-92BE-E64450D7D397Q34604042-ED46A5D2-2732-4E95-96E5-2AA60E430784Q34998994-5E4873A5-B173-4D9A-86CE-241764B1BDD3Q35060446-7F555D61-615A-492C-8BEB-DAAEE28CD6C7Q35061331-63D7BA80-5604-4626-A89D-558FDFE476F2Q35085393-9AEA384D-DB53-4B66-ABC1-6D5C29E23B3EQ35098091-1DCA2107-BCDB-4BC3-AE30-7938AE2D3F80Q35209365-7403C4A9-FB0F-46D4-987E-1E99951305F6Q35653923-21604F02-FDEF-4A50-B53E-2F32F0C01D4FQ35666387-CDF36B26-6555-40AA-B1FB-5215A68F5177Q35770556-B02BA2CA-7383-4616-8060-0FF0A5323ED2Q35947034-BC7FFB55-B317-4241-878D-FC1480C63FA9Q36022324-3E119A04-A386-49A6-B9DF-7302CDC7E179Q36068263-CC69DB54-8F60-4F8F-BD89-E8D76FC0F02AQ36105442-4297FC55-CDA7-4A42-A2D2-F893494DA767Q36178421-F3E12642-222D-4910-9885-EE4906D8F4E3Q36184966-64AC92C9-A9D0-4272-9191-A283D610B391Q36229610-B1953619-A7D5-4B38-94EA-B6B627BC354FQ36457913-942EFCA2-D647-4AF7-A820-BD78BEA6EB7EQ36524069-3B87ECC5-E117-4CD3-BB77-14B95CA589C9Q36557877-097D142F-8837-43C4-AB96-EAB917A8083AQ36694967-1C0C39AE-ADC1-40BF-823B-179117984351
P2860
Diverse tumorigenic pathways in ovarian serous carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Diverse tumorigenic pathways in ovarian serous carcinoma.
@ast
Diverse tumorigenic pathways in ovarian serous carcinoma.
@en
type
label
Diverse tumorigenic pathways in ovarian serous carcinoma.
@ast
Diverse tumorigenic pathways in ovarian serous carcinoma.
@en
prefLabel
Diverse tumorigenic pathways in ovarian serous carcinoma.
@ast
Diverse tumorigenic pathways in ovarian serous carcinoma.
@en
P2093
P2860
P1476
Diverse tumorigenic pathways in ovarian serous carcinoma.
@en
P2093
Gad Singer
Hsueh-Wei Chang
Ie-Ming Shih
Robert J Kurman
Sarah K R Cho
P2860
P304
P356
10.1016/S0002-9440(10)62549-7
P407
P577
2002-04-01T00:00:00Z